Can NK cells maintain the remission of MS?
Natural killer cells from multiple sclerosis patients in remission have properties resembling those of NK type 2 cells, which can favour functional deviation of T cells toward Th2 and prohibit autoimmune effector T cells.
Mar 15, 2001
Multiple sclerosis (MS) is a Th1-mediated autoimmune disease characterised by relapses followed by clinically stable remissions. A new hypothesis suggests that regulatory immune cells may play an active part not only in relapses but also in maintaining the remission of MS. In the
Kazuya Takahashi and colleagues examined NK cells in the peripheral blood of 22 patients with MS and found that during remissions these cells were characterized by an elevation of IL-5 mRNA and a decreased expression of IL-12Rβ2 mRNA. Moreover, the NK cells produced larger amounts of IL- 5 than controls after non-specific stimulation.
These features resemble those of NK type 2 cells, which can favour functional deviation of T cells toward...
Interested in reading more?
Become a Member of
